| Active ingredient (INN) | Normosol |
|---|---|
| Therapeutic category | Auto-created by Health Canada — Recalls and Safety Alerts scraper |
| Controlled substance | No |
| Marketing-authorisation holders | ICU Medical Inc., ABBOTT LABORATORIES, LIMITED, ICU MEDICAL CANADA INC |
| Registrations on file |
|---|
| 6 |
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Normosol-R | 30; 37; 222; 526; 502mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL | injection | 🇺🇸 US | ICU Medical Inc. | Active |
| Normosol-M And Dextrose | 5; 21; 128; 234g/100mL; mg/100mL; mg/100mL; mg/100mL | injection | 🇺🇸 US | ICU Medical Inc. | Active |
| Normosol-R and Dextrose | 5; 30; 37; 222; 526; 502g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL | injection | 🇺🇸 US | ICU Medical Inc. | Active |
| Normosol-R | — | liquid | 🇨🇦 CA | ABBOTT LABORATORIES, LIMITED | Active |
| Normosol-R & 5% Dextrose | 5% | solution | 🇨🇦 CA | ICU MEDICAL CANADA INC | Active |
| Normosol-M & 5% Dextrose | 5% | solution | 🇨🇦 CA | ICU MEDICAL CANADA INC | Active |